Williams Eugene
SEC Form 4 insider trading activity
Williams Eugene has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Nov 3, 2026.
On the most recent filing, Williams Eugene is listed as Director at ProMIS Neurosciences Inc. Inside the rolling window, Williams Eugene reported 5 open-market purchases totaling $146K in PMN and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,000 PMN shares on Mar 5, 2026, worth $49K.
Companies traded
Other insiders at PMN
Insider Buying
$146K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Williams Eugene made?
Williams Eugene has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Williams Eugene trade?
Williams Eugene has filed SEC Form 4 disclosures for 1 company, including PMN.
When was Williams Eugene's most recent SEC Form 4 filing?
Williams Eugene's most recent SEC Form 4 filing on Tracefour is dated Nov 3, 2026.
What is Williams Eugene's total buy and sell value in the current window?
Inside the rolling retention window, Williams Eugene bought $146K and sold $0 based on SEC Form 4 filings.
What was Williams Eugene's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,000 PMN shares on 2026-03-05, worth $49K, per SEC Form 4 filings.